Prepared exclusively for
Gulf Breeze Apothecary
How to Scale Your Sterile Compounding Operation from $500K/Month to $10M+/Month
Leveraging 30+ State Licensing to Systematically Build Prescriber Partnerships Across Weight Loss (GLP-1), Peptide Therapy, BHRT, Pain Management & Specialty Sterile Compounding
March 2026
Here's What We Heard
From our conversation on March 24, 2026
$500K/mo
Current Monthly Revenue
Up from $150K/mo at the beginning of last year
$10M/mo
Revenue Goal
Within the next 3 years
30+
States Licensed
Massive addressable market
7
Sales Team
5 field reps + 2 phone reps, hiring 3 more
GLP-1
Primary Revenue Driver
Weight loss clinics and wellness centers
Peptides
Next Wave
Positioned for day-one launch when regulations clear
You told us your GLP-1 channel is working through your sales team. You're aggressively scaling. You're licensed in 30+ states. And you've spent significant budget with a previous agency on retail ads, LinkedIn bots, and a telehealth funnel that produced zero leads. You're done wasting money. You want something that actually works.